Mesh vs Suture Techniques for Pelvic Organ Prolapse
(COMET Trial)
Trial Summary
What is the purpose of this trial?
This is a Canadian, multi-centre, double-blind randomized controlled trial of an innovative vaginal surgery technique for correction of pelvic organ prolapse (POP) in women. Vaginal surgery is preferred as minimally invasive, however the investigators do not know if materials such as synthetic polypropylene mesh improve success, durability and cost-effectiveness long-term. The investigators principal goal is to compare the experimental bilateral sacrospinous vaginal vault fixation with synthetic mesh arms (BSSVF-M) to the current standard of sacrospinous ligament suspension with synthetic sutures (SSLS) over a timeline of 2 years. Patients and evaluators will be blind to technique.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment BSSVF-M Procedure, SSLS Procedure for pelvic organ prolapse?
Research shows that using anterior vaginal mesh combined with sacrospinous ligament fixation (SSF) has better long-term success rates for treating advanced pelvic organ prolapse compared to other methods, with low complication rates. Additionally, both unilateral and bilateral sacrospinous ligament fixation techniques are considered safe and effective for treating pelvic organ prolapse.12345
Is the Mesh vs Suture Technique for Pelvic Organ Prolapse safe?
The sacrospinous ligament fixation (SSLF) procedure, whether using mesh or native tissue, is generally considered safe with low rates of serious complications and recurrence. Studies show that both unilateral and bilateral SSLF techniques have similar safety profiles, and the use of mesh may reduce the risk of needing another surgery for recurrence.15678
How does the BSSVF-M and SSLS treatment for pelvic organ prolapse differ from other treatments?
The BSSVF-M and SSLS treatment for pelvic organ prolapse is unique because it combines mesh and suture techniques, potentially offering better long-term success rates compared to traditional suture-only methods, with a low rate of complications. This approach may provide improved anatomical support and durability for patients with advanced pelvic organ prolapse.135910
Eligibility Criteria
This trial is for women over 19 with bothersome pelvic organ prolapse, who can read and write in English, and commit to follow-up visits for two years. It excludes pregnant or breastfeeding women, those with prior vaginal mesh surgery or pelvic radiation, immune-compromised individuals, current smokers, and those with certain pain syndromes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either BSSVF-M or SSLS surgery for pelvic organ prolapse
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Participants' health benefits and costs of surgery are estimated using a Markov model
Treatment Details
Interventions
- BSSVF-M Procedure
- SSLS Procedure
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Centre for Health Evaluation and Outcome Sciences
Collaborator
University of Alberta
Collaborator
McGill University
Collaborator
McMaster University
Collaborator